EVENT DOSSIER
In September 2026, Boston Scientific revealed that the cyberattack last month caused business disruptions, making it difficult to achieve third-quarter and annual sales growth as well as adjusted earnings per share targets. On August 25, the company shut down some systems to contain the unauthorized activities; this incident affected the business applications used for processing and shipping customer orders. Currently, the distribution network has largely returned to normal, with major distribution centers achieving or exceeding normal processing and shipping levels. Sterilization facilities are operating normally, and most manufacturing sites worldwide have resumed operations. The interruption in new patient activations for remote monitoring of specific cardiac devices has also been resolved. Although devices not connected to the network were unaffected and no evidence of continuous unauthorized access was found, details such as how the attackers infiltrated, whether ransomware was involved, who is responsible, and whether data was stolen remain unclear. The company has not yet determined a specific date for fully resuming operations.
波士顿科学公司（Boston Scientific）披露上月网络攻击导致业务中断，使其难以达成第三季度及全年销售增长和调整后每股收益指引。该公司周二在 SEC filings 中宣布这一重大财务影响，此前于 8 月 25 日检测到未授权活动并关闭部分系统以进行遏制。此次事件影响了用于处理和发货客户订单的业务应用，但具体损失金额尚不明确。目前公司正逐步恢复运营，分销网络已基本恢复正常，主要配送中心处理及发货水平达到或超过正常水平，灭菌设施正常运行，全球多数制造站点已复工，特定心脏设备远程监控的新患者激活中断也已解决。尽管未连接网络的设备不受影响且未发现持续未授权访问证据，但攻击者如何入侵、是否涉及勒索软件、谁负责以及数据是否被盗等细节仍成谜，公司尚未确定完全恢复运营的具体日期。